Pharmacotherapy of depressive disorders in neurological practice: safety and efficacy problems

Author: S.G. Burchinsky

State Institution «Institute of Gerontology named after A.I. D.F. Chebotareva NAMS of Ukraine», Kyiv


The problem of depression is currently one of the leading medical and social problems of modern society. According to various data (not taking into account a significant number of undiagnosed, masked, somatoform, and other variants), there are from 100 to 200 million patients with depression in the world [8, 10, 11, 13], and they experience at least one depressive episode in their life 20-25% of women and 7-12% of men. At the same time, one of the most important characteristics of depressive disorders at the present stage is their going beyond the limits of psychiatric pathology, an increase in the proportion of neurotic and somatogenic forms compared to classical endogenous depressions (mono- and bipolar disorders). Thus, at present, the proportion of non-psychotic forms in the overall structure of depressive pathology exceeds 60% [2]. This is the reason for the fact that in recent years an increasing number of such patients are turning not to a psychiatrist, but to a primary care doctor – a district therapist, or – in the case of somatogenic depression – to doctors of other specialties, but mostly to neurologists.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design